An MRI assessment of prostate cancer local recurrence using the PI-RR system: diagnostic accuracy, inter-observer

Paolo Niccolò Franco1,2, Sofia Frade-Santos3,4, Alejandra García-Baizán3

  • 1Department of Radiology, Hospital Universitario de Vigo, Carretera Clara Campoamor 341, 36312, Vigo, Spain. francopaoloniccolo@gmail.com.

European Radiology
|August 30, 2023
PubMed
Abstract

Insights

The Prostate Imaging for Recurrence Reporting (PI-RR) system shows good accuracy and reliability for MRI detection of prostate cancer recurrence after treatment. This standardized approach improves consistency among radiologists assessing local recurrence.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Standardized MRI assessment is crucial for detecting prostate cancer (PCa) local recurrence post-treatment.
  • The Prostate Imaging for Recurrence Reporting (PI-RR) system aims to standardize MRI interpretation for PCa recurrence.

Purpose of the Study:

  • Evaluate the diagnostic accuracy of the PI-RR system.
  • Assess inter-observer reliability of PI-RR among radiologists with varying experience.
  • Correlate PI-RR findings with clinical and pathological data.

Main Methods:

  • Retrospective analysis of pelvic MRIs in 120 patients with suspected PCa recurrence.
  • Independent PI-RR scoring by five radiologists (two senior, three junior).
  • Reference standard established via follow-up data; inter-observer reliability assessed using Cohen's kappa and ICC.

Main Results:

  • PI-RR demonstrated good diagnostic performance (sensitivity 79-86%, specificity 64-86%, accuracy 79-87%).
  • Excellent inter-observer reliability was observed (kappa 0.52-0.77, ICC 0.8) across all experience levels.
  • Prostate-specific antigen (PSA) parameters predicted local recurrence on imaging.

Conclusions:

  • The PI-RR system is effective for MRI evaluation of PCa local recurrence.
  • It promotes uniformity and standardization in assessing patients with biochemical recurrence.
  • PI-RR is a promising tool for improving consistency in prostate MRI interpretation.